Royal Bank Of Canada Neurocrine Biosciences Inc Transaction History

Royal Bank Of Canada

$423 Billion
Q2 2024

A detailed history of Royal Bank Of Canada transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 165,429 shares of NBIX stock, worth $20.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

165,429

Previous 167,427 1.19%

Holding current value

$20.8 Million

Previous $23 Million 1.19%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Nov 06, 2024	SELL	$130.86 - $143.19 $261,458 - $286,093	-1,998 Reduced 1.19%	165,429 $22.8 Million
Q2 2024 Aug 14, 2024	BUY	$130.86 - $143.19 $640,297 - $700,628	4,893 Added 3.01%	167,427 $23 Million
Q1 2024 Nov 05, 2024	SELL	$130.4 - $143.74 $3.71 Million - $4.09 Million	-28,453 Reduced 16.99%	138,974 $19.2 Million
Q1 2024 May 15, 2024	BUY	$130.4 - $143.74 $5.21 Million - $5.75 Million	39,987 Added 32.63%	162,534 $22.4 Million
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $7.89 Million - $9.88 Million	74,419 Added 154.63%	122,547 $16.1 Million
Q3 2023 Nov 14, 2023	BUY	$94.02 - $117.1 $397,986 - $495,684	4,233 Added 9.64%	48,128 $5.41 Million
Q2 2023 Aug 14, 2023	SELL	$89.53 - $104.87 $6.61 Million - $7.74 Million	-73,828 Reduced 62.71%	43,895 $4.14 Million
Q1 2023 May 15, 2023	SELL	$94.11 - $123.02 $341,525 - $446,439	-3,629 Reduced 2.99%	117,723 $11.9 Million
Q4 2022 Feb 14, 2023	BUY	$106.72 - $127.06 $795,490 - $947,105	7,454 Added 6.54%	121,352 $14.5 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $549,695 - $643,949	5,973 Added 5.53%	113,898 $12.1 Million
Q2 2022 Aug 15, 2022	BUY	$75.79 - $100.07 $2.77 Million - $3.66 Million	36,590 Added 51.29%	107,925 $10.5 Million
Q1 2022 May 16, 2022	BUY	$72.45 - $94.81 $710,734 - $930,086	9,810 Added 15.94%	71,335 $6.69 Million
Q4 2021 Feb 14, 2022	BUY	$79.65 - $106.22 $141,538 - $188,752	1,777 Added 2.97%	61,525 $5.24 Million
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $666,257 - $765,600	-7,731 Reduced 11.46%	59,748 $5.73 Million
Q2 2021 Aug 16, 2021	BUY	$89.43 - $102.27 $6.03 Million - $6.9 Million	67,479 New	67,479 $6.57 Million

Others Institutions Holding NBIX

# of Institutions

629

Shares Held

94.2M

Call Options Held

692K

Put Options Held

406K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Neurocrine Biosciences Inc Transaction History